The escalating tariff war between the United States and the Chinese mainland is casting a shadow over the hard-won counternarcotics cooperation between the two nations. On Tuesday, U.S. President-elect Donald Trump announced plans to impose an additional 10 percent tariff on all Chinese goods entering the United States. He cited what he perceives as insufficient efforts by China to curb the flow of fentanyl into the U.S. market.
This accusation not only lacks a factual basis but also risks undermining the collaborative efforts essential in tackling the global fentanyl crisis. Such statements may hinder progress in joint initiatives that are crucial for both countries.
Contrary to Trump’s claims, the Chinese mainland has made significant strides in combating the production and trafficking of fentanyl and its analogues. Recognizing the global challenge posed by these substances, China has implemented rigorous legislative measures and strengthened law enforcement both domestically and internationally.
In a groundbreaking move on May 1, 2019, China became the first country to categorize all fentanyl-related substances as controlled substances. This comprehensive scheduling means that any unauthorized production, sale, or trafficking of these substances is subject to severe legal penalties. This action demonstrates China’s commitment to addressing the issue proactively.
Further reinforcing its stance, China has introduced three additional legal documents focused on the prosecution and conviction of crimes involving fentanyl-related substances. These measures enhance the legal framework necessary to deter illicit activities effectively.
On September 1, 2024, China tightened controls on key fentanyl precursors, including 4-AP, 1-boc-4-AP, and norfentanyl. The production and sale of these chemicals now require official licenses, and their export is subject to stringent scrutiny. These steps are critical in disrupting the supply chain of illegal fentanyl production.
The Chinese mainland’s proactive measures reflect a genuine commitment to international counternarcotics efforts. By imposing additional tariffs based on unfounded accusations, the United States risks damaging a vital partnership. Instead of resorting to trade penalties, it would be more productive to enhance dialogue and cooperation to combat the shared threat of fentanyl abuse.
The global nature of the fentanyl crisis demands collaboration, not confrontation. It is imperative that both nations work together to strengthen their counternarcotics strategies for the safety and well-being of their citizens and the international community.
Reference(s):
Tariff war will only impede Sino-U.S. counternarcotics cooperation
cgtn.com
